Rockwell Medical - 21 Year Stock Price History | RMTI

Historical daily share price chart and data for Rockwell Medical since 1998 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Rockwell Medical as of January 23, 2019 is 3.08.
Rockwell Medical Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 3.1127 2.7800 3.4700 2.7600 3.0800 36.28%
2018 4.8016 5.6400 6.7600 2.2600 2.2600 -61.17%
2017 6.7022 6.4400 8.8200 5.2700 5.8200 -11.15%
2016 7.3155 9.4400 10.0400 4.5100 6.5500 -36.04%
2015 11.4989 10.1500 18.6900 7.3200 10.2400 -0.39%
2014 10.5721 10.4300 14.2700 8.1600 10.2800 -1.53%
2013 7.0573 8.1300 15.5900 3.2600 10.4400 29.69%
2012 8.6608 9.7000 11.6100 5.2500 8.0500 -4.96%
2011 9.7452 7.9700 16.5500 6.8900 8.4700 7.22%
2010 6.5166 7.7900 8.6800 4.2000 7.9000 2.73%
2009 6.1893 4.1200 9.3100 2.5600 7.6900 83.53%
2008 5.1805 7.2000 7.4900 1.4982 4.1900 -41.64%
2007 6.2803 7.1100 8.0000 4.6600 7.1800 0.70%
2006 6.7097 4.4300 9.1700 3.9400 7.1300 59.51%
2005 3.5136 3.3000 5.0500 2.7400 4.4700 41.90%
2004 3.2981 4.1900 4.4400 2.2500 3.1500 -21.05%
2003 2.0328 0.5000 3.9900 0.4400 3.9900 576.27%
2002 1.3093 1.4000 2.8400 0.5000 0.5900 -57.86%
2001 0.9768 0.7500 1.7500 0.3750 1.4000 86.67%
2000 2.1988 2.8400 5.2500 0.5000 0.7500 -73.63%
1999 3.4023 2.7500 4.6250 2.0000 2.8440 13.76%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.178B $0.057B
Rockwell Medical Technologies, Inc. manufactures hemodialysis concentrates and dialysis kits, and sells, distributes and delivers such concentrates and dialysis kits, as well as other ancillary hemodialysis products, to hemodialysis providers in the United States. Hemodialysis is a process which is able to duplicate kidney function in patients whose kidneys have failed to function properly.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $125.560B 25.44
Medtronic (MDT) Ireland $116.845B 17.47
Stryker (SYK) United States $62.070B 23.40
Boston Scientific (BSX) United States $51.560B 26.06
Baxter (BAX) United States $37.069B 23.94
Zimmer Biomet Holdings (ZBH) United States $21.197B 13.75
ResMed (RMD) United States $16.739B 31.92
Smith & Nephew SNATS (SNN) United Kingdom $16.480B 0.00
Canopy Growth (CGC) Canada $10.136B 0.00
Bio-Rad Laboratories (BIO) United States $7.056B 45.12
Hill-Rom Holdings (HRC) United States $6.447B 20.36
Aurora Cannabis (ACB) Canada $6.178B 32.58
Perrigo (PRGO) Ireland $6.105B 9.27
Haemonetics (HAE) United States $5.072B 44.61
ICU Medical (ICUI) United States $4.894B 27.27
Insulet (PODD) United States $4.517B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.200B 0.00
Neogen (NEOG) United States $3.138B 48.21
Agios Pharmaceuticals (AGIO) United States $3.041B 0.00
Hutchison China MediTech (HCM) China $2.918B 0.00
National Vision Holdings (EYE) United States $2.467B 47.72
NuVasive (NUVA) United States $2.457B 22.87
Quidel (QDEL) United States $2.042B 26.63
NxStage Medical (NXTM) United States $1.891B 0.00
Aphria (APHA) $1.768B 78.67
Phibro Animal Health (PAHC) United States $1.259B 17.82
AtriCure (ATRC) United States $1.203B 0.00
VAREX IMAGING (VREX) United States $1.038B 20.79
Cardiovascular Systems (CSII) United States $1.001B 1441.00
PetIQ (PETQ) United States $0.788B 20.43
Cerus (CERS) United States $0.764B 0.00
OraSure Technologies (OSUR) United States $0.739B 41.59
Meridian Bioscience (VIVO) United States $0.703B 22.42
Omeros (OMER) United States $0.651B 0.00
Surmodics (SRDX) United States $0.645B 97.61
Eagle Pharmaceuticals (EGRX) United States $0.627B 20.11
Lantheus Holdings (LNTH) United States $0.625B 19.36
NanoString Technologies (NSTG) United States $0.623B 0.00
MacroGenics (MGNX) United States $0.487B 0.00
Owens & Minor (OMI) United States $0.481B 5.44
Quanterix (QTRX) United States $0.449B 0.00
LeMaitre Vascular (LMAT) United States $0.449B 22.04
Evolus (EOLS) United States $0.443B 0.00
TG Therapeutics (TGTX) United States $0.361B 0.00
Utah Medical Products (UTMD) United States $0.314B 20.31
Insys Therapeutics (INSY) United States $0.305B 0.00
Bovie Medical (APYX) United States $0.280B 0.00
Vapotherm (VAPO) United States $0.273B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.268B 0.00
Cytosorbents (CTSO) United States $0.230B 0.00
BioLife Solutions (BLFS) United States $0.229B 310.00
Fonar (FONR) United States $0.137B 6.88
Chimerix (CMRX) United States $0.132B 0.00
Surface Oncology (SURF) United States $0.132B 0.00
Chembio Diagnostics (CEMI) United States $0.120B 0.00
United-Guardian (UG) United States $0.086B 18.00
Female Health (VERU) United States $0.085B 0.00
InfuSystems Holdings (INFU) United States $0.069B 0.00
Trinity Biotech (TRIB) Ireland $0.060B 16.73
Oramed Pharmaceuticals (ORMP) United States $0.059B 0.00
CAS Medical Systems (CASM) United States $0.056B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Neurotrope (NTRP) United States $0.031B 0.00
Myomo (MYO) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.020B 0.00
Senestech (SNES) United States $0.019B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00